August 27, 2026 | Intelligent Congress, Pharma, healthcare
This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.

Congresses remain one of the most influential moments in the HCP journey, but many organizations still struggle to connect strategy, engagement, and measurement across the congress lifecycle. As a result, valuable opportunities to maximize impact are often missed.
Our latest Intelligent Congress guidebook introduces a practical four-step framework to help pharma teams transform congresses from isolated activities into connected, measurable experiences. Covering strategic alignment, integrated measurement, seamless HCP engagement, and streamlined execution, it provides a roadmap for creating more coordinated congress strategies that deliver greater business impact.
Download here.
This content was provided by Inizio
Latest Content from Inizio
The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.
Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.
Authored by: Constanza Salas, Jhon Galindo and Rachel Howard
The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry
Authored by: Marc Garcia and Tania Rodrigues
How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.
Living with COPD 2023
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics.
With over 20 years’ experience in the industry, Research Partnership Senior Director and market research veteran Andrew Stokes has been appointed Chief Commercial Officer.
Find out how we provided a more holistic understanding of brand equity and a forward indication of potential market share using our advanced analytics solution, Equity AI.
